No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.

@article{Geurts2011NoSE,
  title={No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.},
  author={Sandra M. E. Geurts and Anne M van Altena and Femmie de Vegt and Vivianne C. G. Tjan-Heijnen and Leon Fag Massuger and Jos A van Dijck and Nicolaas A. M. Verbeek},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2011},
  volume={21 4},
  pages={
          647-53
        }
}
INTRODUCTION Routine follow-up is standard medical practice in ovarian cancer patients treated with curative intent. However, no strong evidence exists indicating that prognosis is improved. The objective of this study was to evaluate the routine follow-up schedule for ovarian cancer patients regarding the adherence to the Dutch protocol, the detection of recurrences, and the follow-up's impact on overall survival. METHODS All 579 consecutive patients diagnosed with epithelial ovarian… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Epithelial ovarian carcinoma: National guideline

  • Massuger LFAG, Kruitwagen RFPM, Coppens JMB
  • Version 1. Available at: www.oncoline.nl: CRGO;
  • 2009

Similar Papers

Loading similar papers…